Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_provenance.
- NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_assertion description "[Our findings indicate that AAV-mediated PEDF gene expression may offer an active approach to inhibit LLC growth and that treatment with AAV-PEDF may provide a promising therapeutic strategy in lung cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_provenance.
- NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_assertion evidence source_evidence_literature NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_provenance.
- NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_assertion SIO_000772 22218393 NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_provenance.
- NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_assertion wasDerivedFrom befree-20150227 NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_provenance.
- NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_assertion wasGeneratedBy ECO_0000203 NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP615737.RAl6HBl3e2WeUZlMqn1Ykek9kg80uK881-c8_Vu9KREwE130_provenance.